Blood Collection Biorepository for Liver Disease Research
NCT03025074 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-08-27
Summary
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Conditions
- Non-Alcoholic Steatohepatitis(NASH)
- Hepatitis C
- Hepatitis B
- Fibrosis
- Cirrhosis
- Fatty Liver
- Obesity, Childhood
- Bariatric Surgery Candidate
Sponsors & Collaborators
-
State University of New York at Buffalo
lead OTHER
Principal Investigators
-
Andrew Talal, MD · University at Buffalo
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2099-12-31
- Completion
- 2099-12-31
Countries
- United States
Study Locations
More Related Trials
-
Methods to Detect Liver Fibrosis
NCT03027700 ·Status: TERMINATED ·Phase: NA
-
Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver
NCT02682173 ·Status: COMPLETED ·Phase: NA
-
MRI to Measure Liver Fat Content
NCT00594412 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression
NCT02267148 ·Status: COMPLETED
-
Liquid Biopsy for NASH and Liver Fibrosis
NCT04677101 ·Status: COMPLETED
-
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
NCT02897908 ·Status: RECRUITING
-
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
NCT01747772 ·Status: COMPLETED ·Phase: NA
-
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
NCT07149571 ·Status: RECRUITING
-
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
NCT04807868 ·Status: RECRUITING
-
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
NCT04720560 ·Status: RECRUITING
-
Functional Assessment in Liver Transplantation
NCT03870568 ·Status: TERMINATED
-
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
NCT04690972 ·Status: RECRUITING
-
Observational Study of Biomarker During Liver Surgery
NCT02102971 ·Status: TERMINATED
-
Liver and Biliary Tumor Tissue Registry
NCT02917759 ·Status: TERMINATED
-
Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment
NCT05384652 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of Hepatic Fibrosis Using 4D-MRI
NCT05385237 ·Status: RECRUITING ·Phase: NA
-
Development of a Novel Biomarker for Liver Fibrosis
NCT02348814 ·Status: COMPLETED
-
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
NCT07051863 ·Status: RECRUITING
-
Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
NCT01600105 ·Status: COMPLETED ·Phase: PHASE4
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients
NCT02477462 ·Status: COMPLETED
-
Biomarkers of Liver Fibrosis
NCT02438917 ·Status: TERMINATED
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
NCT01324414 ·Status: COMPLETED